end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccountsPayableOtherCurrent,AccountsPayableRelatedPartiesCurrent,AccountsPayableTradeCurrent,AccountsReceivableGrossCurrent,AccountsReceivableRelatedPartiesCurrent,AccruedLiabilitiesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapital,AdditionalPaidInCapitalCommonStock,AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AdjustmentsToAdditionalPaidInCapitalWarrantIssued,AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities,AllocatedShareBasedCompensationExpense,AmortizationOfAcquisitionCosts,AmortizationOfDebtDiscountPremium,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,AssetsFairValueDisclosure,BridgeLoan,BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued,BusinessAcquisitionPercentageOfVotingInterestsAcquired,BusinessCombinationConsiderationTransferred1,BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents,BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets,BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther,BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet,CashAcquiredFromAcquisition,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsPeriodIncreaseDecrease,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1,ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights,ClassOfWarrantOrRightOutstanding,CommonStockParOrStatedValuePerShare,CommonStockParOrStatedValuePerShare,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockSharesSubscriptions,CommonStockValue,ComprehensiveIncomeNetOfTax,ConvertibleNotesPayableCurrent,CurrentFederalTaxExpenseBenefit,CurrentForeignTaxExpenseBenefit,DebtInstrumentConvertibleBeneficialConversionFeature,DebtInstrumentConvertibleConversionPrice1,DebtInstrumentFaceAmount,DebtInstrumentUnamortizedDiscount,DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction,DebtRelatedCommitmentFeesAndDebtIssuanceCosts,DeferredFederalIncomeTaxExpenseBenefit,DeferredFinanceCostsCurrentNet,DeferredForeignIncomeTaxExpenseBenefit,DeferredOfferingCosts,DeferredTaxAssetsGoodwillAndIntangibleAssets,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsValuationAllowance,DepositAssets,Depreciation,DepreciationDepletionAndAmortization,DerivativeFairValueOfDerivativeLiability,DerivativeGainLossOnDerivativeNet,DueToOfficersOrStockholdersCurrent,DueToOtherRelatedPartiesCurrentAndNoncurrent,EarningsPerShareBasicAndDiluted,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential,EffectiveIncomeTaxRateReconciliationTaxCredits,EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,EmployeeRelatedLiabilitiesCurrent,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,EquityIssuancePerShareAmount,EquityIssuancePerShareAmount,EscrowDeposit,FairValueAdjustmentOfWarrants,FairValueAssumptionsExpectedDividendRate,FairValueAssumptionsExpectedVolatilityRate,FairValueAssumptionsRiskFreeInterestRate,FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements,FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs,FinancialLiabilitiesFairValueDisclosure,FinancingInterestExpense,ForeignCurrencyTransactionGainBeforeTax,ForeignCurrencyTransactionGainLossBeforeTax,ForeignCurrencyTransactionGainLossRealized,ForeignCurrencyTransactionLossBeforeTax,GainLossOnSaleOfDerivatives,GainLossRelatedToLitigationSettlement,GeneralAndAdministrativeExpense,Goodwill,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,IncomeTaxExpenseBenefit,IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance,IncomeTaxReconciliationChangeInEnactedTaxRate,IncomeTaxReconciliationDispositionOfBusiness,IncomeTaxReconciliationForeignIncomeTaxRateDifferential,IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate,IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost,IncomeTaxReconciliationOtherAdjustments,IncomeTaxReconciliationPriorYearIncomeTaxes,IncomeTaxReconciliationTaxCredits,IncomeTaxReconciliationTaxCredits,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInAccountsPayableTrade,IncreaseDecreaseInAccountsReceivable,IncreaseDecreaseInAccruedLiabilities,IncreaseDecreaseInOtherAccountsPayable,IncreaseDecreaseInOtherNoncurrentLiabilities,IncreaseDecreaseInOtherOperatingLiabilities,IntangibleAssetsNetExcludingGoodwill,InterestExpense,InterestExpenseDebt,InterestExpenseOther,InterestPaid,InterestPaidNet,InvestmentIncomeInterest,IssuanceOfStockAndWarrantsForServicesOrClaims,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LiabilitiesNoncurrent,LitigationSettlementAmountAwardedToOtherParty,LitigationSettlementExpense,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetIncomeLoss,NetIncomeLossAvailableToCommonStockholdersBasic,NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1,NonoperatingIncomeExpense,NumberOfReportableSegments,OperatingExpenses,OperatingIncomeLoss,OperatingLeasesFutureMinimumPaymentsDue,OperatingLeasesFutureMinimumPaymentsDueCurrent,OperatingLeasesFutureMinimumPaymentsDueInFourYears,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLeasesFutureMinimumPaymentsDueThereafter,OperatingLeasesRentExpenseMinimumRentals,OperatingLeasesRentExpenseNet,OperatingLossCarryforwards,OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent,OtherComprehensiveIncomeLossNetOfTax,OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent,OtherComprehensiveIncomeLossTax,OtherFinancialServicesCosts,OtherLiabilitiesNoncurrent,OtherNonoperatingExpense,OtherNonoperatingIncome,OtherNonoperatingIncomeExpense,OtherRestrictedAssetsCurrent,PaymentsOfStockIssuanceCosts,PaymentsToAcquirePropertyPlantAndEquipment,PaymentsToAcquireRestrictedInvestments,PaymentsToAcquireShortTermInvestments,PaymentsToFundLongtermLoansToRelatedParties,PrepaidExpenseAndOtherAssetsCurrent,PrepaidExpenseCurrent,ProceedsFromConvertibleDebt,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfPrivatePlacement,ProceedsFromIssuanceOfWarrants,ProceedsFromOtherEquity,ProceedsFromPaymentsForLongTermLoansForRelatedParties,ProceedsFromRelatedPartyDebt,ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments,ProceedsFromSaleOfPropertyPlantAndEquipment,ProceedsFromWarrantExercises,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,RelatedPartyTransactionAmountsOfTransaction,RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty,RepaymentsOfConvertibleDebt,RepaymentsOfRelatedPartyDebt,ResearchAndDevelopmentExpense,RestrictedCashAndCashEquivalents,RestrictedCashAndCashEquivalentsNoncurrent,RetainedEarningsAccumulatedDeficit,SaleOfStockPricePerShare,SellingGeneralAndAdministrativeExpense,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares,SharePrice,SharePrice,SharesIssuedPricePerShare,ShortTermInvestments,StockholdersEquity,StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities,StockIssuedDuringPeriodSharesNewIssues,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueAcquisitions,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueEmployeeBenefitPlan,StockIssuedDuringPeriodValueIssuedForServices,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValuePurchaseOfAssets,StockIssuedDuringPeriodValueShareBasedCompensation,StockIssuedDuringPeriodValueShareBasedCompensationGross,StockIssuedDuringPeriodValueStockOptionsExercised,StockOptionPlanExpense,StockRepurchasedDuringPeriodValue,TaxesOther,UnrecognizedTaxBenefits,ValueAddedTaxReceivableCurrent,WarrantsAndRightsOutstanding,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesOutstandingBasic
2014-12-31,2015-02-11,10-K,Akari Therapeutics Plc,AKTX,CIK0001541157,USD,555528.0,356000.0,39236.0,1003000.0,,0.0,42999.0,,46081.0,,2445494.0,,,,470729.0,410000.0,0.0,0.0,0.0,3394666.0,3335249.0,,,,,,,,,,0.0,3327468.0,2773814.0,,,,,,,0.01,0.01,5000000000.0,722345600.0,722345600.0,,11210804.0,-1868115.0,,0.0,0.0,,,,,,0.0,0.0,,0.0,,,0.0,2407332.0,,0.0,2407332.0,0.0,3051.0,4942.0,,,533605.0,,-0.02,0.215,,,15262.0,,4000.0,313000.0,,,0.6,,0.0,,,,0.0,552000.0,,0.0,,,0.0,-22909.0,,,549000.0,,,,-332663.0,-1947553.0,-1614890.0,0.0,572139.0,,0.0,-153415.0,-418724.0,0.0,,0.0,1033484.0,,474209.0,351000.0,,0.0,-223000.0,33000.0,0.0,59417.0,5436.0,,,5400.0,,91.0,0.0,1171368.0,3394666.0,1171368.0,0.0,,,4235376.0,4235376.0,0.0,0.0,-1476824.0,-1476824.0,-1947553.0,-9648000.0,,-28254.0,,1919299.0,-1919299.0,1454000.0,289000.0,330000.0,313000.0,297000.0,225000.0,1561000.0,1800.0,,79438.0,,79438.0,,0.0,33000.0,20000.0,549000.0,529000.0,142000.0,0.0,0.0,142000.0,0.0,0.0,7781.0,,0.0,,3690723.0,,8219000.0,112300.0,0.0,432353.0,0.0,,,67000.0,0.0,25000.0,749000.0,0.0,0.0,1616204.0,,0.0,-11479081.0,,303095.0,0.0,,,,,,,,1490727.0,1.39,,145000.0,845000.0,,0.0,2903227.0,1.42,0.0,2903227.0,1.42,,,1.61,0.7,0.0,,,0.01,,0.57,,2223298.0,,,,3690723.0,,,56000.0,8219000.0,,412000.0,412000.0,,,0.0,0.0,,,,85515588.0,85515588.0,85515588.0
2015-03-31,2015-05-12,10-Q,Akari Therapeutics Plc,AKTX,CIK0001541157,USD,,614000.0,,296000.0,,,,,,,34175000.0,,,,-291692.0,,,,0.0,4317000.0,4273000.0,,,,,,,,,,,1328662.0,-1998806.0,,,,,,,0.01,,5000000000.0,55636283.0,55636283.0,,927000.0,-1672931.0,,,,,,,,,,,,,,,,,,,,,764.0,,,,,,-0.002,,,,-10328.0,,,,252000.0,,2.0,,,0.0,,,0.0,-539000.0,,774000.0,,,0.0,-37601.0,,,,,,,,-1696786.0,,0.0,,,,,,,,,,,-282411.0,-707000.0,,,258000.0,5000.0,0.0,,4556.0,,,2636.0,,0.0,,,4317000.0,910000.0,812000.0,,,0.0,,0.0,,-1988478.0,,-1696786.0,,,-42157.0,,1654629.0,-1654629.0,1383000.0,218000.0,330000.0,313000.0,297000.0,225000.0,,,2308000.0,23855.0,,,,,38000.0,,,-535000.0,142000.0,,0.0,,,,,,,,,,0.0,,,,,,,,44000.0,40000.0,,,,1554950.0,,,-32507000.0,,99679.0,0.0,,,,,,,,1515727.0,1.36,,0.0,0.0,,0.0,2903227.0,1.42,0.0,2903227.0,1.42,,,0.0,0.0,0.0,,,,,0.57,,2595000.0,,,,,,,,,,59000.0,59000.0,,,,0.0,,,,722345600.0,722345600.0,722345600.0
2015-06-30,2015-08-12,10-Q,Akari Therapeutics Plc,AKTX,CIK0001541157,USD,,331000.0,,629000.0,,,,,,,34224000.0,,,,,,,,,2960000.0,2920000.0,,,,,,,,,,,201444.0,,,,,,,,0.01,,5000000000.0,55636283.0,55636283.0,,927000.0,-1319549.0,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.002,,,,,,,,172000.0,,,,,,,,0.0,,,984000.0,,,,-22.0,,,,,,,,-1671000.0,,0.0,,,,,,,,,,,,,,,,,,,2613.0,,,,,0.0,,,2960000.0,960000.0,1027000.0,,,,,,,,,-1340768.0,,,-28755.0,,1312013.0,-1312013.0,1312000.0,147000.0,330000.0,313000.0,297000.0,225000.0,,,2308000.0,21219.0,-1671000.0,,0.0,,43000.0,,,-215000.0,142000.0,,,,,,,,,,,,,,,,,,,,40000.0,,,,,1001180.0,,,-34178000.0,,310833.0,,,,,,,,,1753227.0,1.26,,,,,0.0,2703227.0,1.47,0.0,2703227.0,1.47,,,,,0.0,,,,,,,973000.0,,,,,,,,,,,,,,,26120.0,,,,,722345600.0,
2015-09-30,2015-11-23,10-Q,Akari Therapeutics Plc,AKTX,CIK0001541157,USD,3753518.0,,0.0,,,,3845928.0,,197091.0,,86062364.0,,,,,,19283280.0,,63845378.0,79174139.0,78939029.0,,,,0.9168,,,,,,,78772888.0,,,,,,1150276.0,,0.01,,5000000000.0,1177693383.0,1177693383.0,,18340894.0,-48778952.0,,,,,,,3000000.0,,,,,,,,,,,,,142079.0,,,,,3031304.0,,-0.06,,,,,,,11400000.0,,,,,,,,,638691.0,,,27165905.0,26004442.0,,,-22.0,,,,,,,,-48735690.0,,0.0,,,,,,,,,,,,,,,,,,58099.0,3054262.0,,,,,1445.0,,37842693.0,79174139.0,37796655.0,46038.0,,,,,,,,,-48735690.0,,,-25408711.0,,23326979.0,-23326979.0,,,,,,,,,,-43262.0,,,,22973138.0,,,,,,,,,,,,,,,,,,,,,,,,,34932.0,,,,,1313265.0,,,-63268903.0,,2730434.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41331446.0,,,,,,,,,,,,,,,21425.0,,,,781738789.0,781738789.0,781738789.0
2015-12-31,2016-03-23,10-K,Akari Therapeutics Plc,AKTX,CIK0001541157,USD,4320588.0,,0.0,,,10366.0,408222.0,,156480.0,,87018764.0,,1039866.0,,40351949.0,,19283280.0,3031304.0,68950724.0,69893562.0,69658487.0,,,,0.9168,,,,,,1410577.0,68919995.0,65592527.0,69062074.0,,,,1782246.0,,0.01,0.01,5000000000.0,1177693383.0,1177693383.0,,18340894.0,-45207133.0,,0.0,0.0,,,,3000000.0,,,0.0,,0.0,,,0.0,11162545.0,3181481.0,210573.0,14554599.0,,7040.0,10162.0,685141.0,,0.0,,-0.05,0.2025,,0.145,121893.0,,,11149000.0,,,,,-11408231.0,0.0,,,11408231.0,,,,,23000000.0,0.0,0.0,-90588.0,,,0.0,,,-39599123.0,-45317532.0,-5718409.0,0.0,7447002.0,0.0,3904864.0,-1964914.0,-9176800.0,-225748.0,,15596.0,,578000.0,3755173.0,,,,,,3469.0,52483.0,3053948.0,3000000.0,3000000.0,22945.0,22945.0,20705.0,750000.0,21174037.0,69893562.0,21124968.0,49069.0,,0.0,69044419.0,69044419.0,1391798.0,1391798.0,-4965583.0,-4965583.0,-45317532.0,,,-14732962.0,,30584570.0,-30584570.0,,,,,,,,104000.0,,110399.0,,110399.0,,22973138.0,,,,,,5425646.0,10560.0,,0.0,8219.0,728126.0,,,,75000000.0,,,0.0,-8219.0,3031304.0,0.0,,,,40513.0,131000.0,,,3561239.0,5799076.0,,142079.0,-56796613.0,,5502214.0,1039866.0,,,,,,,,2882017.0,,,,,,0.0,61362198.0,0.34,,,,5806280.0,,,,,26000000.0,,,,,0.0,48719525.0,,,,20339140.0,,,750000.0,69574354.0,,,,,,,44224.0,,,,852088530.0,852088530.0,852088530.0
2016-03-31,2016-05-12,10-Q,Akari Therapeutics Plc,AKTX,CIK0001541157,USD,625372.0,,,,,10717.0,231905.0,,-36464.0,,87835569.0,,816805.0,,-4455192.0,,,,79950724.0,62959202.0,62693347.0,,,,0.9168,,,,,,,61429511.0,-7490484.0,,,,,1782246.0,,0.01,,5000000000.0,1177693383.0,1177693383.0,,18340894.0,-3178328.0,,,,,,,,,,,,,,,,,,,,,8594.0,,522565.0,,,,-0.003,,,,-7825.0,,,,,,,,162576.0,,,,704335.0,,,,,23000000.0,178699.0,154431.0,,,,,,,,-2985384.0,,0.0,,,,,,,,,,,-3876501.0,,,,,,3031.0,49019.0,0.0,,3000000.0,0.0,,30804.0,,16601200.0,62959202.0,16549100.0,52100.0,,,,,-42083.0,,-7440576.0,,-2985384.0,,,866594.0,,3851978.0,-3851978.0,,,,,,,,,,-192944.0,,-192944.0,,,,,,,,,42083.0,,,,1253119.0,,,,,,,,,,,,,,74757.0,12000.0,,,,1499543.0,,142079.0,-59781997.0,,2352435.0,816805.0,,,,,,,,9492456.0,,,,,,,72362198.0,,,,,5806280.0,,,,,,,,,,,46358002.0,,,,,,,,,,,,,,,22976.0,,,,1177693383.0,1177693383.0,1177693383.0
